Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07032948
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Registry
-
NCT07032948
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07032948. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-31 (anticipated); primary completion 2025-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function
- Condition
- Rapid Arrhythmia
- Condition
- Atrial Fibrillation (AF)
- Condition
- Paroxysmal Supraventricular Tachycardia (PSVT)
- Intervention (Device)
- FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter、EasyStars™ High Density Mapping Catheter、Columbus™ 3D EP Navigation System
- Lead sponsor
- Shanghai MicroPort EP MedTech Co., Ltd.
Record details
- Record id
cardio:ct-nct07032948- Content hash
c7342ecdeb52070efd03f9d1ce57799e253273e4b8db3126dd0bebf255e7c8b7